BGS vs BIIB · rev $792.2M vs P/E 21, rev $9.89B
B&G Foods Inc (BGS) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
B&G Foods Inc (BGS) is a packaged foods company listed on NYSE.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Latest reported BGS revenue for 2026-07-04 was $792.2M. Net income was -$36.5M. Revenue was up 93.7% from 2026-04-04 to 2026-07-04. BGS currently screens at market cap $316.6M.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
BGS currently screens at market cap $316.6M. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the BGS and BIIB stock pages for the full models.
Not investment advice.